secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001104659-23-001912
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health receives Nasdaq delisting notice for bid price below $0.10 for 10 days
--------------------------------------------------------------------------------

- Nasdaq notified Jaguar Health on Jan 5, 2023 that its common stock bid price closed below $0.10 for 10 consecutive trading days, triggering delisting under Rule 5810(c)(3)(A)(iii).
- Company intends to request a hearing before the Nasdaq Hearings Panel to appeal; request will stay delisting pending hearing and potential extension.
- Jaguar Health also must regain compliance with $1.00 minimum bid price rule by Feb 13, 2023, having been granted a 180-day grace period.
- Special stockholder meeting scheduled for Jan 20, 2023 to vote on reverse stock split (ratio of 1-for-3 to 1-for-75) to potentially regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000110465923001912/0001104659-23-001912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000110465923001912/tm232344d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-001912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer